However, we found no significant difference in Choi et al.34 DUX4 target levels between FSHD and control samples in any of the five microarray data sets or on meta-analysis (Fig. 2a–b). The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.